Page 184 - Read Online

Cui et al. Diagnosis and treatment of meningeal carcinomatosis

intrathecally administered chemotherapy and outcome in patients with Assessment in Neuro-Oncology critical review of endpoints and
leptomeningeal metastases. Neurology 1998;50:438-44. response criteria of published randomized clinical trials. Neuro Oncol
44. Chamberlain MC, Corey-Bloom J. Leptomeningeal metastases: 2014;16:1176-85.
111indium-DTPA CSF flow studies. Neurology 1991;41:1765-9. 60. Hitchins RN, Bell DR, Woods RL, Levi JA. A prospective randomized
45. DeAngelis LM. Current diagnosis and treatment of leptomeningeal trial of single-agent versus combination chemotherapy in meningeal
metastasis. J Neurooncol 1998;38:245-52. carcinomatosis. J Clin Oncol 1987;5:1655-62.
46. Lin N, Dunn IF, Glantz M, Allison DL, Jensen R, Johnson MD, 61. Bleyer WA, Drake JC, Chabner BA. Neurotoxicity and elevated
Friedlander RM, Kesari S. Benefit of ventriculoperitoneal cerebrospinal cerebrospinal-fluid methotrexate concentration in meningeal
fluid shunting and intrathecal chemotherapy in neoplastic meningitis: leukemia. N Engl J Med 1973;289:770-3.
a retrospective, case-controlled study. J Neurosurg 2011;115:730-6. 62. Giannone L, Greco FA, Hainsworth JD. Combination intraventricular
47. Zhang XH, Wang XG, Piao YZ, Wang P, Li P, Li WL. Lumboperitoneal chemotherapy for meningeal neoplasia. J Clin Oncol 1986;4:68-73.
shunt for the treatment of leptomeningeal metastasis. Med Hypotheses 63. Glantz MJ, Cole BF, Glantz LK, Cobb J, Mills P, Lekos A, Walters
2015;84:506-8. BC, Recht LD. Cerebrospinal fluid cytology in patients with cancer:
48. Yamashiro S, Hitoshi Y, Tajiri S, Uchikawa H, Ito K, Yoshida A, minimizing false-negative results. Cancer 1998;82:733-9.
Kuratsu JI. Palliative lumboperitoneal shunt for leptomeningeal 64. Chamberlain MC, Khatibi S, Kim JC, Howell SB, Chatelut E, Kim
metastasis-related hydrocephalus: a case series. Palliat Med S. Treatment of leptomeningeal metastasis with intraventricular
2017;31:93-6. administration of depot cytarabine (DTC 101). A phase I study. Arch
49. Sandberg DI, Bilsky MH, Souweidane MM, Bzdil J, Gutin PH. Neurol 1993;50:261-4.
Ommaya reservoirs for the treatment of leptomeningeal metastases. 65. Ongerboer de Visser BW, Somers R, Nooyen WH, van Heerde
Neurosurgery 2000;47:49-54; discussion 54-5. P, Hart AA, McVie JG. Intraventricular methotrexate therapy of
50. Souchon R, Feyer P, Thomssen C, Fehm T, Diel I, Nitz U, Janni W, leptomeningeal metastasis from breast carcinoma. Neurology
Bischoff J, Sauer R. Clinical recommendations of DEGRO and AGO 1983;33:1565-72.
on preferred standard palliative radiotherapy of bone and cerebral 66. Grossman SA, Trump DL, Chen DC, Thompson G, Camargo EE.
metastases, metastatic spinal cord compression, and leptomeningeal Cerebrospinal fluid flow abnormalities in patients with neoplastic
carcinomatosis in breast cancer. Breast Care (Basel) 2010;5:401-7. meningitis. An evaluation using 111indium-DTPA ventriculography.
51. Brem SS, Bierman PJ, Black P, Blumenthal DT, Brem H, Am J Med 1982;73:641-7.
Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, 67. Sause WT, Crowley J, Eyre HJ, Rivkin SE, Pugh RP, Quagliana
Fine HA, Friedman A, Glass J, Grossman SA, Heimberger AB, Junck JM, Taylor SA, Molnar B. Whole brain irradiation and intrathecal
L, Levin V, Loeffler JJ, Maor MH, Narayana A, Newton HB, Olivi methotrexate in the treatment of solid tumor leptomeningeal
A, Portnow J, Prados M, Raizer JJ, Rosenfeld SS, Shrieve DC, Sills metastases -- a Southwest Oncology Group study. J Neurooncol
AK, Jr., Spence AM, Vrionis FD. Central nervous system cancers: 1988;6:107-12.
clinical practice guidelines in oncology. J Natl Compr Canc Netw 68. Esteva FJ, Soh LT, Holmes FA, Plunkett W, Meyers CA, Forman
2005;3:644-90. AD, Hortobagyi GN. Phase II trial and pharmacokinetic evaluation
52. Salgia S, Fleming GF, Lukas RV. Leptomeningeal carcinomatosis of cytosine arabinoside for leptomeningeal metastases from breast
from breast cancer treated with intrathecal topotecan with concomitant cancer. Cancer Chemother Pharmacol 2000;46:382-6.
intravenous eribulin. J Clin Neurosci 2014;21:1250-1. 69. Glantz MJ, LaFollette S, Jaeckle KA, Shapiro W, Swinnen L,
53. Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L, Rozental JR, Phuphanich S, Rogers LR, Gutheil JC, Batchelor T,
Swinnen LJ, Maria B, LaFollette S, Schumann GB, Cole BF, Howell Lyter D, Chamberlain M, Maria BL, Schiffer C, Bashir R, Thomas
SB. A randomized controlled trial comparing intrathecal sustained- D, Cowens W, Howell SB. Randomized trial of a slow-release versus
release cytarabine (DepoCyt) to intrathecal methotrexate in patients a standard formulation of cytarabine for the intrathecal treatment of
with neoplastic meningitis from solid tumors. Clin Cancer Res lymphomatous meningitis. J Clin Oncol 1999;17:3110-6.
1999;5:3394-402. 70. Cole BF, Glantz MJ, Jaeckle KA, Chamberlain MC, Mackowiak JI.
54. Oliveira M, Braga S, Passos-Coelho JL, Fonseca R, Oliveira J. Quality-of-life-adjusted survival comparison of sustained-release
Complete response in HER2+ leptomeningeal carcinomatosis from cytosine arabinoside versus intrathecal methotrexate for treatment
breast cancer with intrathecal trastuzumab. Breast Cancer Res Treat of solid tumor neoplastic meningitis. Cancer 2003;97:3053-60.
2011;127:841-4. 71. Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL,
55. Mego M, Sycova-Mila Z, Obertova J, Rajec J, Liskova S, Palacka Moynihan T, Ettinger DS. Randomized prospective comparison of
P, Porsok S, Mardiak J. Intrathecal administration of trastuzumab intraventricular methotrexate and thiotepa in patients with previously
with cytarabine and methotrexate in breast cancer patients with untreated neoplastic meningitis. Eastern Cooperative Oncology
leptomeningeal carcinomatosis. Breast 2011;20:478-80. Group. J Clin Oncol 1993;11:561-9.
56. Chang EL, Lo S. Diagnosis and management of central nervous 72. Blaney SM, Heideman R, Berg S, Adamson P, Gillespie A, Geyer JR,
system metastases from breast cancer. Oncologist 2003;8:398-410. Packer R, Matthay K, Jaeckle K, Cole D, Kuttesch N, Poplack DG,
57. Groves MD, Glantz MJ, Chamberlain MC, Baumgartner KE, Conrad Balis FM. Phase I clinical trial of intrathecal topotecan in patients with
CA, Hsu S, Wefel JS, Gilbert MR, Ictech S, Hunter KU, Forman AD, neoplastic meningitis. J Clin Oncol 2003;21:143-7.
Puduvalli VK, Colman H, Hess KR, Yung WK. A multicenter phase II 73. Samlowski WE, Park KJ, Galinsky RE, Ward JH, Schumann
trial of intrathecal topotecan in patients with meningeal malignancies. GB. Intrathecal administration of interleukin-2 for meningeal
Neuro Oncol 2008;10:208-15. carcinomatosis due to malignant melanoma: sequential evaluation
58. Niwinska A. Brain metastases as site of first and isolated recurrence of intracranial pressure, cerebrospinal fluid cytology, and cytokine
of breast cancer: the role of systemic therapy after local treatment. induction. J Immunother Emphasis Tumor Immunol 1993;13:49-54.
Clin Exp Metastasis 2016;33:677-85. 74. Chamberlain MC. A phase II trial of intra-cerebrospinal fluid
59. Chamberlain M, Soffietti R, Raizer J, Ruda R, Brandsma D, Boogerd alpha interferon in the treatment of neoplastic meningitis. Cancer
W, Taillibert S, Groves MD, Le Rhun E, Junck L, van den Bent 2002;94:2675-80.
M, Wen PY, Jaeckle KA. Leptomeningeal metastasis: a Response 75. Brown MT, Coleman RE, Friedman AH, Friedman HS, McLendon
176 Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ September 18, 2017